Astrazeneca Stock Profile

<div class='circular--portrait' style='background:#0D8ECF;color: white;font-size:4em;padding-top: 25px;;'>AS</div>


0 / 100

Odds of Distress

Equity ratings for Astrazeneca PLC are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting November 27, 2019 and ending today February 25, 2020. Click here to learn more.

Astrazeneca PLC Profile

Next fiscal quarter end is expected on March 31, 2020. AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom. Astrazeneca PLC operates under Drug Manufacturers - General classification in USA and is traded on BATS Exchange. more on Astrazeneca PLC
Astrazeneca PLC Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Astrazeneca PLC SEC Filings
Astrazeneca PLC SEC Filings
Security & Exchange Commission EDGAR ReportsView All
Legal NameAstrazeneca PLC
ChairmanLeif JohanssonView All
Thematic Classifications
Active investing themes Astrazeneca PLC currently participates. An investing theme is an unweighted collection of funds, stocks, ETFs or cryptocurrencies
showing 2 out of 3 themes  View All
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering Astrazeneca PLC
Piotroski F Score
Academic score to determine the current strength of Astrazeneca PLC financial position
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
Financial Strength
Astrazeneca PLC ability to generate sufficient cash flow to pay bills, repay debt, and make consistent year-to-year profit
Total Debt
Debt Current
Debt Non Current
Long Term Debt to Equity
Debt to Equity Ratio
Return on Investment
Return on Average Assets
Return on Average Equity
Return on Invested Capital
Return on Sales
Earnings per Basic Share
Earnings per Diluted Share
Price to Earnings Ratio
Earnings before Tax
Average Bond Rating: AA-Very Strong
Few selected profitability drivers of Astrazeneca PLC representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Consolidated Income
Net Income
Net Income Common Stock
Operating Income
Income Tax Expense
Net Income Per Employee
Operating Margin
Gross Margin
Profit Margin
Astrazeneca PLC (AZN) is traded on BATS Exchange in USA. It is located in 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom and employs 64,400 people. Astrazeneca PLC is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with total capitalization of 127.36 B. Astrazeneca PLC runs under Healthcare sector within Drug Manufacturers?General industry. The entity has 2.62 B outstanding shares of which 4.03 M shares are presently shorted by investors with about 2.63 days to cover shorted positions. ASTRAZENECA PLC A has about 4.78 B in cash with 3.82 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.82.
Check Astrazeneca PLC Probability Of Bankruptcy

Ownership Allocation (%)

Astrazeneca Stock Price Odds Analysis

Odds Below 47.64HorizonTargetOdds Above 47.64
6.29%30 days 47.64 93.56%
Based on normal probability distribution, the odds of Astrazeneca PLC to move above current price in 30 days from now is more than 94.0 (This Astrazeneca PLC probability density function shows the probability of Astrazeneca PLC Stock to fall within a particular range of prices over 30 days) .

Astrazeneca Stock Top Holders

Astrazeneca PLC Income Statement Over Time

Astrazeneca Stock Against Markets

Did you try this?

Run Portfolio Volatility Now


Portfolio Volatility

Check portfolio volatility and analyze historical return density to properly model market risk
All  Next Launch Module

Astrazeneca PLC Upcoming and Recent Events

Astrazeneca PLC Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportApril 24, 2020
Next Earnings ReportJuly 23, 2020
Next Fiscal Quarter EndMarch 31, 2020
Next Fiscal Year EndFebruary 12, 2021
Last Quarter Report DateDecember 31, 2019
Last Earning Anouncement DateMarch 31, 2019

Astrazeneca PLC Corporate Filings

Astrazeneca PLC SEC Reporting

Unclassified Corporate Event

Astrazeneca PLC Corporate Directors

Marc Dunoyer Chief Financial Officer, Executive Director
Sherilyn McCoy Non-Executive Independent Director
Genevieve Berger Non-Executive Independent Director
Please continue to Trending Equities. Please also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Company logos by clearbit